Inbunden, Engelska, 2018
Del 18 i serien Resistance to Targeted Anti-Cancer Therapeutics
Resistance to Ibritumomab in Lymphoma
Av Makoto Hosono, Jean-François Chatal
1469 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Finns i fler format
Beskrivning
Produktinformation
- Utgivningsdatum: 2018-05-07
- Mått: 155 x 235 x 16 mm
- Vikt: 378 g
- Format: Inbunden
- Språk: Engelska
- Serie: Resistance to Targeted Anti-Cancer Therapeutics
- Antal sidor: 158
- Upplaga: 18001
- Förlag: Springer International Publishing AG
- ISBN: 9783319782379
Utforska kategorier
Mer information
Makoto Hosono, MD, PhD, is a Professor of Radiology and Nuclear Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Japan, and serves as a member of Committee 3, International Commission on Radiological Protection. Jean-François Chatal, MD, PhD, is an Emeritus Professor of Nuclear Medicine at the University of Nantes, France. He is one of the international leaders who developed radioimmunotherapy, that is, therapy using radiolabeled anti-tumor antibodies. He created and headed an INSERM research laboratory and also initiated the installation of a cyclotron institute termed ARRONAX for the production of novel radionuclides for nuclear medicine.
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.